Articles published by Innate Pharma SA
![](https://mms.businesswire.com/media/20231102579006/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Announces New Clinical Data for Lacutamab and SAR443579/IPH6101 at ASH 2023
November 03, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20231026262265/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20231018004853/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma 2024 Financial Calendar
October 19, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20231015522683/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Announces Abstracts Selected for ESMO Congress 2023
October 16, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20231008198770/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20231004595765/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Provides Update on Lacutamab Clinical Program
October 05, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20230921031989/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230913337651/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Reports First Half 2023 Financial Results and Business Update
September 14, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20230828906538/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230809103086/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma to Participate in Upcoming Investor Conference
August 10, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20230710291669/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230706452631/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230625819940/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230615028516/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230611748794/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230609005396/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230607005831/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230606005767/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230525005888/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230522005342/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230512005280/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230509006263/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230508005100/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230502005834/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230502006194/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230426005995/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230420005521/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma to Participate in Upcoming Investor Conference
April 21, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20230417005517/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20230406005537/en/1245155/22/INNATEvertnoirDS.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.